How much does it cost to purchase giritinib (segatan) in China?

Gilteritinib is a new oral therapeutic drug mainly used to treat a rare but serious blood system disease called acute myeloid leukemia (AML). Acute myeloid leukemia is a type of leukemia caused by the abnormal proliferation of immature white blood cells in the bone marrow. It blocks the production of normal blood cells, leading to reduced immune system function, susceptibility to infection, anemia and other symptoms.

Although giritinib has been launched in the domestic market, unfortunately, it has not yet been included in the scope of medical insurance. Therefore, its domestic price is relatively high, with a single purchase costing more than 20,000 yuan. If you need more specific price information, it is recommended to consult your local hospital or pharmacy directly.

In comparison, the prices of foreign generic drugs are more affordable, especially those produced in Laos, which cost only about two to three thousand yuan, which is far lower than the domestic selling price. It is worth mentioning that these generic drugs have basically the same ingredients as the domestic original drugs, and therefore have a high degree of similarity in efficacy.

Giritinib is a tyrosine kinase inhibitor that works by inhibiting the activity ofFLT3, a tyrosine kinase receptor. FLT3 is an abnormal protein commonly found in AML patients, and its mutations are closely related to the development and progression of AML. Giritinib inhibits the growth and proliferation of leukemia cells by interfering with the FLT3 signal transduction pathway, thereby prolonging patients' survival and improving their quality of life.

Clinical trials have shown that giritinib has shown significant efficacy in the treatment ofAML patients. Compared with traditional treatment, giritinib can significantly prolong the progression-free survival (PFS) of patients and improve the treatment response rate. This makes giritinib a promising treatment option, especially for patients with FLT3 mutation-positive AML.